The New Scientist published an article a few weeks ago called How to keep your brain blooming. It’s written by by James Goodwin, someone who knows a lot about brains.Continue reading “Blooming brain”
Hot off the research press is a journal article with a self-explanatory title: Effects of exercise on sleep in neurodegenerative disease.
It starts by summarising the main things that affect sleep in people with Parkinson’s, Alzheimer’s and other neurodegenerative diseases as being:
- damage to the sleep-wake system in the brain, that affects the circadian rhythm and disrupts normal sleeping and waking patterns; and
- “secondary mechanisms” which include a raft of things like medication side effects, having to get up to the toilet during the night, poor sleep “hygiene”, sleep-related breathing disorders, and the environment in which you try to sleep.
Below is an excellent article written by Gretchen Reynolds, first published in the New York Times and reprinted in The Age on 1 December 2020. Reynolds describes new research into the effect of movement on molecules in the blood and what that might mean for quality of life and length of life.
If you’ve ever thought that exercise of any degree or duration is over-rated, then this is the article for you: Link
Alzheimer’s disease researchers have had to do a complete revision of thinking. For decades, the focus has been on getting rid of an abnormal protein, called amyloid, that plonks itself in the brains of people with Alzheimer’s.
It was a reasonable hypothesis. Amyloid and Alzheimer’s seem to go together, so it seemed logical that in getting rid of amyloid proteins, Alzheimer’s would be cured.
Billions of dollars later, and despite lots of trials with amyloid-chewing drugs, it seems that amyloid is not the culprit.
Q: So what is the culprit?
A: Lots of things, especially mitochondria, the batteries that power our cells.
It’s not a surprise that miserable mitochondria are heavily involved in Alzheimer’s. More and more evidence is showing that moping mitochondria appear in many different diseases. It seems that cell battery management is critical, which makes a lot of sense.
The number of articles linking Alzheimer’s and mitochondria are increasing, and the hope is to find pharmaceutical solutions. That’s good, but there is a solution already in place. And one without side effects.
Photobiomodulation acts on the cell mitochondria, the cell batteries, and boosts the cell activity, stimulates the cell nucleus to start making new cells, opens up the blood vessels and stimulates the blood vessels to sprout more branches. We know from research, case studies and observations of people with Alzheimer’s disease that red and near infrared transcranial lights used daily can improve memory, judgement, attention and concentration, mood, apathy, sleep quality, fatigue, not to mention increasing enjoyment of life.
It would be so good if some of those billions of dollars for Alzheimer’s research would include more work on photobiomodulation.
1. Stojakovic, A., Trushin, S., Sheu, A. et al. Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice. Commun Biol 4, 61 (2021). https://doi.org/10.1038/s42003-020-01584-y Link.
2. Bell, Simon M.; Barnes, Katy; De Marco, Matteo; Shaw, Pamela J.; Ferraiuolo, Laura; Blackburn, Daniel J.; Venneri, Annalena; Mortiboys, Heather. 2021. “Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?” Biomedicines 9, no. 1: 63. Link